FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384199564> ?p ?o ?g. }

• W4384199564 abstract "Abstract Low-invasive biomarkers are urgently needed for the detection of molecular pathology in Frontotemporal Dementia (FTD), FTD spectrum disorders and Amyotrophic Lateral Sclerosis (ALS). This is particularly true in behavior variant FTD (bvFTD), in which premortem biomarkers are missing to distinguish underlying Tau from TAR DNA binding protein (TDP-43) pathology. This lack of biomarkers prevents the stratification of patients for intervention trials and constitutes a major obstacle for the development of disease-modifying therapies. Extracellular vesicles (EVs) have been implicated in neurodegenerative disease pathology, contributing to the release and potentially to intercellular transmission of pathologically aggregated proteins. Here, we show that plasma EVs contain quantifiable amounts of TDP-43 and full-length Tau, which allows the quantification of 3 repeat (3R) and 4 repeat (4R) Tau isoforms. Plasma EV TDP-43 levels and EV 3R/4R Tau ratios were determined in a pilot and validation study of 704 patients, including 37 genetic and 31 neuropathologically proven cases. Diagnostic groups comprised patients with the TDP-43 proteinopathy ALS, the 4R tauopathy Progressive Supranuclear Palsy (PSP), bvFTD as a group with either Tau or TDP-43 pathology, and healthy controls (HC). Compared to HC, plasma EV 3R/4R Tau ratios were decreased in PSP, unchanged in ALS, and increased in a subset of bvFTD patients, consistent with Tau pathology in approximately 40% of cases with bvFTD. EV Tau ratio discriminated between PSP and bvFTD, ALS and healthy controls (AUC 0.96-0.99), and between bvFTD and ALS (AUC 0.90) as well as HC (AUC 0.91). Plasma EV TDP-43 levels were increased in ALS and in those bvFTD patients who did not display high EV Tau ratios. Plasma EV TDP-43 discriminated patients with ALS from HC (AUC 0.99), bvFTD (AUC 0.91) and PSP (AUC 0.99). The combination of EV Tau ratio and EV TDP-43 was reliably able to discriminate between TDP-43 and Tau pathology in bvFTD. This blood-based classification was confirmed in genetic and autopsy proven cases. Both markers strongly correlated with the neurodegeneration marker neurofilament light chain (NfL) as well as with clinical and neuropsychological markers of disease severity in ALS (TDP-43 with ECAS, ALS-FRS-R), bvFTD (TDP-43 and Tau ratio with CDR-SB, CDR plus NACC FTLD) and PSP (Tau ratio with PSP-RS). Taken together, the combination of both markers may aid the molecular diagnosis of FTD, FTD spectrum disorders and ALS, the stratification of patients for therapeutic trials and bears the potential of a biomarker to monitor disease progression and target engagement." @default.
• W4384199564 created "2023-07-14" @default.
• W4384199564 creator A5000608836 @default.
• W4384199564 creator A5002340019 @default.
• W4384199564 creator A5002895582 @default.
• W4384199564 creator A5004173171 @default.
• W4384199564 creator A5004204996 @default.
• W4384199564 creator A5007088399 @default.
• W4384199564 creator A5007540163 @default.
• W4384199564 creator A5007801159 @default.
• W4384199564 creator A5009396465 @default.
• W4384199564 creator A5013040609 @default.
• W4384199564 creator A5014982696 @default.
• W4384199564 creator A5015892420 @default.
• W4384199564 creator A5015967737 @default.
• W4384199564 creator A5019564409 @default.
• W4384199564 creator A5020827587 @default.
• W4384199564 creator A5021920622 @default.
• W4384199564 creator A5022217754 @default.
• W4384199564 creator A5026893551 @default.
• W4384199564 creator A5027958984 @default.
• W4384199564 creator A5030073108 @default.
• W4384199564 creator A5030220194 @default.
• W4384199564 creator A5031173940 @default.
• W4384199564 creator A5031620559 @default.
• W4384199564 creator A5032421989 @default.
• W4384199564 creator A5033304047 @default.
• W4384199564 creator A5037328125 @default.
• W4384199564 creator A5041198772 @default.
• W4384199564 creator A5041380550 @default.
• W4384199564 creator A5045721609 @default.
• W4384199564 creator A5047141760 @default.
• W4384199564 creator A5048249357 @default.
• W4384199564 creator A5049933408 @default.
• W4384199564 creator A5050028517 @default.
• W4384199564 creator A5051059746 @default.
• W4384199564 creator A5051485155 @default.
• W4384199564 creator A5053381812 @default.
• W4384199564 creator A5055109212 @default.
• W4384199564 creator A5055137091 @default.
• W4384199564 creator A5056320938 @default.
• W4384199564 creator A5056764413 @default.
• W4384199564 creator A5057033109 @default.
• W4384199564 creator A5057989264 @default.
• W4384199564 creator A5058010200 @default.
• W4384199564 creator A5058720451 @default.
• W4384199564 creator A5059020389 @default.
• W4384199564 creator A5059133881 @default.
• W4384199564 creator A5062703349 @default.
• W4384199564 creator A5067028619 @default.
• W4384199564 creator A5067488233 @default.
• W4384199564 creator A5067744605 @default.
• W4384199564 creator A5068417558 @default.
• W4384199564 creator A5068749612 @default.
• W4384199564 creator A5069022559 @default.
• W4384199564 creator A5069184646 @default.
• W4384199564 creator A5069402695 @default.
• W4384199564 creator A5069577796 @default.
• W4384199564 creator A5071062652 @default.
• W4384199564 creator A5075596279 @default.
• W4384199564 creator A5075596948 @default.
• W4384199564 creator A5076331208 @default.
• W4384199564 creator A5078440867 @default.
• W4384199564 creator A5079205018 @default.
• W4384199564 creator A5079896442 @default.
• W4384199564 creator A5082914656 @default.
• W4384199564 creator A5084033552 @default.
• W4384199564 creator A5090528130 @default.
• W4384199564 creator A5092463239 @default.
• W4384199564 creator A5092463240 @default.
• W4384199564 date "2023-07-13" @default.
• W4384199564 modified "2023-10-16" @default.
• W4384199564 title "Plasma extracellular vesicle Tau isoform ratios and TDP-43 inform about molecular pathology in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis" @default.
• W4384199564 cites W1847168837 @default.
• W4384199564 cites W1967353707 @default.
• W4384199564 cites W1995903088 @default.
• W4384199564 cites W1999702935 @default.
• W4384199564 cites W2003618511 @default.
• W4384199564 cites W2015171213 @default.
• W4384199564 cites W2024790026 @default.
• W4384199564 cites W2031047184 @default.
• W4384199564 cites W2041875698 @default.
• W4384199564 cites W2047159195 @default.
• W4384199564 cites W2051490456 @default.
• W4384199564 cites W2061489599 @default.
• W4384199564 cites W2067772208 @default.
• W4384199564 cites W2072567125 @default.
• W4384199564 cites W2082050904 @default.
• W4384199564 cites W2085705498 @default.
• W4384199564 cites W2085870059 @default.
• W4384199564 cites W2086233696 @default.
• W4384199564 cites W2087634412 @default.
• W4384199564 cites W2087657384 @default.
• W4384199564 cites W2098567201 @default.
• W4384199564 cites W2102150307 @default.
• W4384199564 cites W2104497060 @default.
• W4384199564 cites W2104550791 @default.
• W4384199564 cites W2106922104 @default.
• W4384199564 cites W2106998054 @default.
• W4384199564 cites W2108381339 @default.

• next